Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 13 studies | 44% ± 18% | |
microglial cell | 10 studies | 30% ± 10% | |
hepatocyte | 6 studies | 62% ± 25% | |
macrophage | 6 studies | 28% ± 11% | |
monocyte | 5 studies | 35% ± 23% | |
GABAergic neuron | 5 studies | 32% ± 9% | |
myeloid cell | 4 studies | 21% ± 6% | |
cholangiocyte | 3 studies | 59% ± 18% | |
glutamatergic neuron | 3 studies | 42% ± 12% | |
dendritic cell | 3 studies | 17% ± 1% | |
alveolar macrophage | 3 studies | 32% ± 7% | |
basal cell | 3 studies | 24% ± 6% | |
interneuron | 3 studies | 39% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 1685.32 | 1807 / 1809 | 90% | 23.25 | 425 / 472 |
ovary | 91% | 407.08 | 163 / 180 | 96% | 15.47 | 411 / 430 |
lung | 100% | 1863.11 | 578 / 578 | 85% | 13.54 | 977 / 1155 |
esophagus | 90% | 1069.13 | 1294 / 1445 | 89% | 18.34 | 163 / 183 |
uterus | 100% | 651.50 | 170 / 170 | 77% | 11.52 | 354 / 459 |
liver | 100% | 4845.90 | 226 / 226 | 72% | 8.41 | 293 / 406 |
thymus | 96% | 444.84 | 629 / 653 | 70% | 9.74 | 423 / 605 |
bladder | 95% | 594.62 | 20 / 21 | 56% | 6.05 | 284 / 504 |
brain | 78% | 458.49 | 2048 / 2642 | 72% | 12.39 | 511 / 705 |
prostate | 95% | 607.82 | 233 / 245 | 54% | 2.64 | 270 / 502 |
breast | 100% | 709.68 | 458 / 459 | 40% | 2.26 | 450 / 1118 |
pancreas | 51% | 179.36 | 168 / 328 | 87% | 8.42 | 154 / 178 |
stomach | 83% | 333.96 | 298 / 359 | 46% | 2.76 | 131 / 286 |
kidney | 75% | 366.80 | 67 / 89 | 49% | 3.38 | 444 / 901 |
intestine | 80% | 365.37 | 771 / 966 | 40% | 2.35 | 211 / 527 |
spleen | 100% | 875.31 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 827.00 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 696.76 | 1303 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 83% | 317.03 | 215 / 258 | 11% | 0.60 | 25 / 230 |
tonsil | 0% | 0 | 0 / 0 | 91% | 16.26 | 41 / 45 |
peripheral blood | 81% | 3134.52 | 757 / 929 | 0% | 0 | 0 / 0 |
heart | 80% | 454.80 | 693 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 23% | 1.02 | 18 / 80 |
muscle | 13% | 47.09 | 103 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.24 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006954 | Biological process | inflammatory response |
GO_1905606 | Biological process | regulation of presynapse assembly |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0045087 | Biological process | innate immune response |
GO_0032736 | Biological process | positive regulation of interleukin-13 production |
GO_0099560 | Biological process | synaptic membrane adhesion |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0038172 | Biological process | interleukin-33-mediated signaling pathway |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0006955 | Biological process | immune response |
GO_0032754 | Biological process | positive regulation of interleukin-5 production |
GO_0099545 | Biological process | trans-synaptic signaling by trans-synaptic complex |
GO_0051965 | Biological process | positive regulation of synapse assembly |
GO_0099151 | Biological process | regulation of postsynaptic density assembly |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0015026 | Molecular function | coreceptor activity |
GO_0002114 | Molecular function | interleukin-33 receptor activity |
GO_0003953 | Molecular function | NAD+ nucleosidase activity |
GO_0005149 | Molecular function | interleukin-1 receptor binding |
GO_0004908 | Molecular function | interleukin-1 receptor activity |
GO_0061809 | Molecular function | NAD+ nucleotidase, cyclic ADP-ribose generating |
Gene name | IL1RAP |
Protein name | Interleukin 1 receptor accessory protein Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (EC 3.2.2.6) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3) |
Synonyms | IL1R3 C3orf13 |
Description | FUNCTION: Coreceptor for IL1RL2 in the IL-36 signaling system (By similarity). Coreceptor with IL1R1 in the IL-1 signaling system. Associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Recruits TOLLIP to the signaling complex. Does not bind to interleukin-1 alone; binding of IL1RN to IL1R1, prevents its association with IL1R1 to form a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. Coreceptor for IL1RL1 in the IL-33 signaling system. Can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity). May play a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (Probable). .; FUNCTION: [Isoform 2]: Associates with secreted ligand-bound IL1R2 and increases the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors . Enhances the ability of secreted IL1R1 to inhibit IL-33 signaling (By similarity). .; FUNCTION: [Isoform 4]: Unable to mediate canonical IL-1 signaling . Required for Src phosphorylation by IL1B. May be involved in IL1B-potentiated NMDA-induced calcium influx in neurons (By similarity). . |
Accessions | C9JT28 ENST00000422485.5 [Q9NPH3-2] ENST00000447382.6 [Q9NPH3-1] C9J1D9 ENST00000422625.5 Q9NPH3 ENST00000412080.1 ENST00000439062.6 [Q9NPH3-1] ENST00000072516.7 [Q9NPH3-1] ENST00000453359.5 C9J9W1 ENST00000342550.6 [Q9NPH3-3] H7C3W4 ENST00000413869.5 [Q9NPH3-3] ENST00000434491.5 ENST00000422940.5 [Q9NPH3-2] ENST00000317757.8 [Q9NPH3-5] |